Skip to Content
Merck
CN
Search Within
Topic
Content Type
Collections
Topic Area
Product Category
Applications

2949-22-6

Applied Filters:
Keyword:'2949-22-6'
Showing 1-10 of 942 results for "2949-22-6" within Site Content
Performing a Separation with IgG Sepharose 6 Fast Flow
Perform a separation with IgG Sepharose 6 Fast Flow from Cytiva, an Affinity Chromatography product for purification of recombinant fusion proteins containing a protein A tail.
Ni Sepharose 6 Fast Flow for Protein Purification
Ni Sepharose 6 Fast Flow purifies histidine-tagged proteins efficiently, offering high cross-linked agarose beads with Ni2+ ions.
Oligonucleotide Standard 6 Mix LC-UV Analysis
Chromolith® RP-18e columns optimize Oligo Standard 6 separation with varied flow rates and ion-pairing reagent evaluation.
Enzymatic Activity of Glucose-6-Phosphatase [EC 3.1.3.9]
To measure glucose-6-phosphatase activity, the Taussky-Shorr method is used. This method is a spectrophotometric stop-rate determination assay that is measured at 660 nm.
Top 6 "Things to Do" for the Use of Pure Water Machines
Top 6 "Things to Do" for the Use of Pure Water Machines
Enzymatic Assay of Glucose-6-Phosphate Dehydrogenase (EC 1.1.1.49)
To measure glucose-6-phosphate dehydrogenase activity, beta-nicotinamide adenine dinucleotide phosphate is used in a spectrophotometric rate determination assay at 340 nm.
World ADC London 2026
Visit booth #22/23 and explore our offering from contract development, manufacturing and testing services, to products and solutions for ADC development and manufacturing.
Recommend 6 efficient experimental products of Merck, and get tips for graduation on time
Recommend 6 efficient experimental products of Merck, and get tips for graduation on time
Dextran
Dextran polymer details: composed mainly of alpha-D-(1-6) linkages with varied branch lengths.
Japan and Singapore Grant CRISPR Patents to Merck
Merck today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have each allowed its patent application for the use of paired CRISPR nickases, bringing Merck’s number of patents to 22 worldwide.
Page 1 of 95